bd 1008 has been researched along with neuropeptide y in 1 studies
| Studies (bd 1008) | Trials (bd 1008) | Recent Studies (post-2010) (bd 1008) | Studies (neuropeptide y) | Trials (neuropeptide y) | Recent Studies (post-2010) (neuropeptide y) |
|---|---|---|---|---|---|
| 28 | 0 | 4 | 10,663 | 152 | 2,269 |
| Protein | Taxonomy | bd 1008 (IC50) | neuropeptide y (IC50) |
|---|---|---|---|
| Neuropeptide Y receptor type 1 | Homo sapiens (human) | 0.0014 | |
| Neuropeptide Y receptor type 2 | Homo sapiens (human) | 0.0003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ault, DT; Werling, LL | 1 |
1 other study(ies) available for bd 1008 and neuropeptide y
| Article | Year |
|---|---|
Differential modulation of NMDA-stimulated [3H]dopamine release from rat striatum by neuropeptide Y and sigma receptor ligands.
Topics: Analgesics; Animals; Corpus Striatum; Cyclohexylamines; Dopamine; Dose-Response Relationship, Drug; Ethylamines; Haloperidol; Male; N-Methylaspartate; Neuropeptide Y; Piperidines; Pyrrolidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, sigma | 1997 |